Search Results 2151-2160 of 17708 for rheumatoid arthritis
... Arthritis, Dystonia, Charcot-Marie-Tooth disease, Angelman syndrome, Foot drop, Flatfeet, In-toeing, Neurologic muscle weakness, Neuropathy, Autoimmune ...
Dr. Westendorf receives grant funding from the U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) within the U.S. National ...
Arthritis Care Res (Hoboken). 2025 Jan 2 Epub 2025 Jan 02. View PubMed; Syal G, Barnes E, Raffals L, Al Kazzi E, Haydek J, Agarwal M, Singh S. Medical ...
Participation eligibility · a. Giant cell arteritis: According to the American College of Rheumatology (ACR) criteria for classification of GCA, meeting at least ...
Brain-Derived Neurotrophic Factor and Its Associations with Metabolism and Physical Activity in a Latino Sample. Metab Syndr Relat Disord. 2019 Mar; 17 (2): ...
Treatment of Factor-Xa Inhibitor-associated Bleeding with Andexanet Alfa or 4 Factor PCC: A Multicenter Feasibility Retrospective Study. West J Emerg Med ...
... factor. Predictive tools are needed to help assess the risk of clonal hematopoiesis progressing to cancer or other conditions. These tools would help ...
Utilization of Vascular Endothelial Growth Factor-C156S in Therapeutic Lymphangiogenesis: A Systematic Review. Lymphat Res Biol. 2022 Dec; 20 (6):580-584 ...
Evans hopes that his research on arthritis and tissue regeneration will lead to improvements in treatment options for people with osteoarthritis and damaged ...
Population attributable risk (PAR) is a function of time because both the prevalence of a risk factor and its effect on exposed individuals may change over ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your Annual Fund gift can drive advancements in cancer care.